Researchers identify a novel autoantigen in narcolepsy, a mimic of a protein from swine flu virus

Sixty seconds on . . . smell training
26 April 2021
Covid-19: UK launches antivirals taskforce to deliver home treatments by autumn
26 April 2021

Researchers identify a novel autoantigen in narcolepsy, a mimic of a protein from swine flu virus

Researchers at the University of Helsinki have identified influenza virus peptides that resemble human protein fragments and can cause an immune response against the body’s own cells due to cross-reactivity. The recently completed study confirms the notion that influenza A (H1N1) virus peptides can trigger an autoimmune reaction in genetically predisposed individuals, that results in the onset of narcolepsy with cataplexy.

Comments are closed.